Wednesday, August 4, 2010

Dangerous Supplements - FDA Releases 12 Supplements to Avoid

Bookmark and Share 
Today the FDA released a list of supplements that are possibly harmful.

12 supplements you should avoid

These supplement ingredients are among those linked by clinical research or case reports to serious side effects. We worked with the Natural Medicines Comprehensive Database, an independent research group that evaluates the safety and effectiveness of nutritional supplements, to develop this list. We think it's wise to avoid all the ingredients on it. Unless otherwise noted, there's insufficient evidence to rate their effectiveness for their purported uses. Dangers listed are not meant to be all-inclusive. 

(also known as)
(aconiti tuber, aconitum, radix aconiti)
Inflammation, joint pain, wounds, gout. Toxicity, nausea, vomiting, low blood pressure, respiratory-system paralysis, heart-rhythm disorders, death. Unsafe. Aconite is the most common cause of severe herbal poisoning in Hong Kong.
(aurantii fructus, Citrus aurantium, zhi shi)
Weight loss, nasal congestion, allergies. Fainting, heart-rhythm disorders, heart attack, stroke, death. Possibly unsafe. Contains synephrine, which is similar to ephedrine, banned by the FDA in 2004. Risks might be higher when taken with herbs that contain caffeine.
(creosote bush, Larrea divaricata, larreastat)
Colds, weight loss, infections, inflammation, cancer, detoxification. Liver damage, kidney problems. Likely unsafe. The FDA advises people not to take chaparral.
(ionic silver, native silver, Silver in suspending agent)
Fungal and other infections, Lyme disease, rosacea, psoriasis, food poisoning, chronic fatigue syndrome, HIV/AIDS. Bluish skin, mucous membrane discoloration, neurological problems, kidney damage. Likely unsafe. The FDA advised consumers about the risk of discoloration on Oct. 6, 2009.
(coughwort, farfarae folium leaf, foalswort)
Cough, sore throat, laryngitis, bronchitis, asthma. Liver damage, cancer. Likely unsafe.
(blackwort, common comfrey, slippery root)
Cough, heavy menstrual periods, chest pain, cancer. Liver damage, cancer. Likely unsafe. The FDA advised manufacturers to remove comfrey products from the market in July 2001.
(heartleaf, Sida cordifolia, silky white mallow)
Nasal congestion, allergies, asthma, weight loss, bronchitis. Heart attack, heart arrhythmia, stroke, death. Likely unsafe. Possible dangers linked with its ephedrine alkaloids banned by the FDA in 2004.
(Ge, Ge-132, germanium-132)
Pain, infections, glaucoma, liver problems, arthritis, osteoporosis, heart disease, HIV/AIDS, cancer. Kidney damage, death. Likely unsafe. The FDA warned in 1993 that it was linked to serious adverse events.
(celandine, chelidonii herba, Chelidonium majus)
Upset stomach, irritable bowel syndrome, liver disorders, detoxification, cancer. Liver damage. Possibly unsafe.
(awa, Piper methysticum, kava-kava)
Anxiety (possibly effective). Liver damage. Possibly unsafe. The FDA issued a warning to consumers in March 2002. Banned in Germany, Canada, and Switzerland.
(asthma weed, Lobelia inflata, pukeweed, vomit wort)
Coughing, bronchitis, asthma, smoking cessation (possibly ineffective). Toxicity; overdose can cause fast heartbeat, very low blood pressure, coma, possibly death. Likely unsafe. The FDA warned in 1993 that it was linked to serious adverse events.
(yohimbine, Corynanthe yohimbi, Corynanthe johimbi)
Aphrodisiac, chest pain, diabetic complications, depression; erectile dysfunction (possibly effective). Usual doses can cause high blood pressure, rapid heart rate; high doses can cause severe low blood pressure, heart problems, death. Possibly unsafe for use without medical supervision because it contains a prescription drug, yohimbine. The FDA warned in 1993 that reports of serious adverse events were under investigation.

No comments:

Post a Comment


This is a legally confirmed "open forum" website that is not responsible for any content posted within. The opinions, articles and comments on this site do not reflect the opinions of the owner of this site, or it's subsidiaries.